|Systematic (IUPAC) name|
|Molar mass||251.296 g/mol[[Script error: No such module "String".]]|
|Script error: No such module "collapsible list".|
Lubazodone (YM-992, YM-35,995) is an antidepressant which was being developed as a treatment for depression but was discontinued. It acts as a serotonin reuptake inhibitor and 5-HT2A receptor antagonist. Lubazodone made it to phase II clinical trials but was discontinued in 2001.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
|α2δ VDCC Blockers|
|35px||This drug article relating to the nervous system is a stub. You can help ssf by expanding it.|